There are errors in the first paragraph of the Binding specificity of NoV to human saliva and gastric mucosa samples section of the Materials and Methods. The correct sentence is: VLPs from sixteen different NoVs used in this study were as follows (strain and sequence accession number); GI.1 (4656, EF547392), GI.3 (3634, EF547393), GI.4 (2876, EF547394), GI.8 (3006, EF547395), GI.11 (2258, EF547396), GII.1 (3101, EF547397), GII.2 (2840, EF547398), GII.3 (3229, EF547399), GII.4 (1207, DQ975270), GII.5 (3611, EF5473400), GII.6 (3612, EF547401), GII.7 (419, EF547402), GII.12 (2087, EF547403), GII.13 (3385, EF547404), GII.14 (2468, EF547405), and GII.15 (3625, EF547406).
Citation: The PLOS ONE Staff (2014) Correction: Blood Group Substances as Potential Therapeutic Agents for the Prevention and Treatment of Infection with Noroviruses Proving Novel Binding Patterns in Human Tissues. PLoS ONE 9(9): e107825. doi:10.1371/journal.pone.0107825
Published: September 3, 2014
Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.